Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology.

Abstract

In patients with heart failure, the beneficial effects of drug and device therapies counteract to some extent ongoing cardiac damage. According to the net balance between these two factors, cardiac geometry and function may improve (reverse remodelling, RR) and even completely normalize (remission), or vice versa progressively deteriorate (adverse remodelling, AR). RR or remission predict a better prognosis, while AR has been associated with worsening clinical status and outcomes. The remodelling process ultimately involves all cardiac chambers, but has been traditionally evaluated in terms of left ventricular volumes and ejection fraction. This is the second part of a review paper by the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology dedicated to ventricular remodelling. This document examines the proposed criteria to diagnose RR and AR, their prevalence and prognostic value, and the variables predicting remodelling in patients managed according to current guidelines. Much attention will be devoted to RR in patients with heart failure with reduced ejection fraction because most studies on cardiac remodelling focused on this setting.

• Authors: Alberto Aimo, Giuseppe Vergaro, Arantxa González, Andrea Barison, Josep Lupón, Victoria Delgado, A Mark Richards, Rudolf A de Boer, Thomas Thum, Henrike Arfsten, Martin Hülsmann, Inês Falcao-Pires, Javier Díez, Roger S Y Foo, Mark Yan Yee Chan, Chukwuemeka G Anene-Nzelu, Magdy Abdelhamid, Stamatis Adamopoulos, Stefan D Anker, Yuri Belenkov, Tuvia Ben Gal, Alain Cohen-Solal, Michael Böhm, Ovidiu Chioncel, Ewa A Jankowska, Finn Gustafsson, Loreena Hill, Tiny Jaarsma, James L Januzzi, Pardeep Jhund, Yuri Lopatin, Lars H Lund, Marco Metra, Davor Milicic, Brenda Moura, Christian Mueller, Wilfried Mullens, Julio Núñez, Massimo F Piepoli, Amina Rakisheva, Arsen D Ristić, Patrick Rossignol, Gianluigi Savarese, Carlo G Tocchetti, Sophie van Linthout, Maurizio Volterrani, Petar Seferovic, Giuseppe Rosano, Andrew J S Coats, Michele Emdin, Antoni Bayes-Genis
• Journal: European journal of heart failure (Eur J Heart Fail) Vol. 24 Issue 6 Pg. 944-958 (06 2022) ISSN: 1879-0844 [Electronic] England
• PMID: 35488811 (Publication Type: Journal Article, Review)
• Copyright: © 2022 European Society of Cardiology.

Chemical References

• Biomarkers

Topics

• Biomarkers
• Cardiology
• Heart Failure
• Humans
• Stroke Volume
• Ventricular Function, Left
• Ventricular Remodeling